Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence

The summary for the Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence: The purpose of this Notice of Funding Opportunity (NOFO) is to develop and implement protocols and recruitment strategies to evaluate the performance (sensitivity and specificity) of HIV tests under development, and/or newly available HIV tests, for use in point-of-care settings in the United States using fresh (unprocessed) specimens such as whole blood and oral fluid.

Federal Grant Title:	Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-PS-20-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.941
CFDA Descriptions:	Information not provided
Current Application Deadline:	April 14th, 2020
Original Application Deadline:	April 14th, 2020
Posted Date:	February 7th, 2020
Creation Date:	February 7th, 2020
Archive Date:	May 14th, 2020
Total Program Funding:	$3,600,000
Maximum Federal Grant Award:	$1,800,000
Minimum Federal Grant Award:	$900,000
Expected Number of Awards:	3
Cost Sharing or Matching:	No
Last Updated:	March 6th, 2020

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Additional Eligibility Categories:
Grant Announcement Contact: Jocelyn Patterson Mosley
[email protected]
Grants Policy
Similar Government Grants: • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Sci...; • Increasing PrEP Use Among Disproportionately Affected Populations in the United States; • Implementation Research on Telehealth Strategies to Support Retention in Care and Treatmen...; • PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices; • Diffusion of Partnership for Health to Health Care and Medical Agencies Serving Persons Li...; • Translating Proven Interventions for Underserved and Emergent High-Risk Populations (REP 7...; • Evaluation of the Relative Effectiveness of Four Public Health Strategies for Providing HI...
More Grants from the Centers for Disease Control and Prevention ERA: • Collaborative research on influenza and other respiratory pathogens in South Africa; • Advancing Public Health Research in Bangladesh; • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...